Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ZY7I
|
||||
Former ID |
DIB004493
|
||||
Drug Name |
MAPKAP kinase 2 inhibitors
|
||||
Synonyms |
MAPKAP kinase 2 inhibitors (inflammation); MAPKAP kinase 2 inhibitors (inflammation), Merck; MAPKAPK-2 inhibitors (inflammation), Merck; MK-2 inhibitors (inflammation), Merck
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [552109] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(ccc(cc1)NC(=S)NCc1nc(cnc1N)CCC)NC(=O)OC(C)(C)C
|
||||
Target and Pathway | |||||
Target(s) | MAPKAP kinase 2 | Target Info | Inhibitor | [543553] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
Serotonin HTR1 Group and FOS Pathway | |||||
p38 MAPK Signaling Pathway | |||||
MAPK Signaling Pathway | |||||
FAS pathway and Stress induction of HSP regulation | |||||
MAP kinase activation in TLR cascade | |||||
Regulation of mRNA Stability by Proteins that Bind AU-rich Elements | |||||
Arachidonic acid metabolism | |||||
Structural Pathway of Interleukin 1 (IL-1) | |||||
Regulation of Microtubule Cytoskeleton | |||||
IL-1 signaling pathway | |||||
NGF signalling via TRKA from the plasma membrane | |||||
MAPK targets/ Nuclear events mediated by MAP kinases | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.